Biography
George Perry is dean of the College of Sciences and professor of biology at The University of Texas at San Antonio Perry is recognized in the field of Alzheimemiddot;s disease research particularly for his work on oxidative stress. Perry received his bachelormiddot;s of arts degree in zoology with high honors from University of California Santa Barbara After graduation he headed to Scripps Institution of Oceanography and obtained his PhD in marine biology under David Epel in 1979 He then received a postdoctoral fellowship in the Department of Cell Biology in the laboratories of Drs Bill Brinkley and Joseph Bryan at Baylor College of Medicine where he laid the foundation for his observations of abnormalities in cell structures
Research Interest
Alzheimer disease Oxidative stress Parkinson disease Cytoskeleton Mitochondria Amyloidosis Neuropathology Cytochemistry.
Biography
As Executive Director of Sidra Ventures, Herlands leads commercialization initiatives and entrepreneurship to support Sidra\'s mission to become a world-class academic health center, focusing on women\'s and children\'s health. Louis Herlands innovates at the crossroads of academia, entrepreneurship, finance, and industry. Herlands brings a broad set of experience and expertise in technology commercialization, licensing, start-ups, and translational research. Herlands leverages his scientific expertise to form, finance, and lead successful biotechnology companies that are developing important new medicines in diverse therapeutic areas including diabetes, obesity, pain due to nerve damage, and cancer. The peak value of the publically traded companies he has co-founded, financed and led is in excess of $8 billion. These companies are based on patented new discoveries that have the ability to transform medicine, and help millions of patients worldwide. Herlands graduated from Yale University and received his PhD from The Rockefeller University.
Research Interest
Biotech and Pharmaceutical Industry
Biography
The supramolecular nanoscale assembly group is a multidisciplinary team of scientists, engineers and technical staff dedicated to understanding the underlying concepts of molecular recognition, self-assembly and self-organization processes, and utilizing this knowledge to advance the health and medical technologies, energy and environment, information and communication technologies, and nanomaterials sectors. The mission of our group is to (a) harness the properties and architecture of matter from the ground up through supramolecular synthesis, self-assembly and self-organization, (b) create new materials for application in sustainable energy generation, catalysis, nanoelectronics, and nanomedicine, (c) develop new technology platforms to address significant public health problems and meet current technological challenges, (d) train highly qualified graduate students, postdoctoral fellows and technical staff. Our group focuses specifically on the development of a variety of nanomaterials (organic nanotubes, metal nanoparticles, nanocrystalline cellulose) for applications as: (a) adaptable scaffolds for drug display/delivery, in particular for cancer, lung inflammation, and bone therapy; (b) coatings for optimal medical device integration in living systems; (c) electroactive and photoactive components for organic photovoltaics and nanoelectronics; (d) catalysts; (e) platforms for ultradetection; (f) components in composite materials. In the context of these investigations, we explore the fundamentals of self-assembly and self-organization processes, to advance the design of materials with predefined dimensions and physical properties, and explore commercialization opportunities in the nanomedical device arena.
Research Interest
Nanotechnology for Biomedical applications, Nanoscale materials for drug delivery, and Cell therapeutics and Regenerative medicine